R-2487 in Patients With Rheumatoid Arthritis (NCT05961592)
A Single and Repeat Dosing Study of the Safety, Drug Exposure and Clinical Activity of R-2487 in Patients With Rheumatoid Arthritis
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-2487) in patients with Rheumatoid Arthritis. Patients will take an oral dosage of probiotic (R-2487) and physicians will assess and measure their Rheumatoid Arthritis. Blood and fecal evaluations of inflammation and assessment of probiotic (R-2487) on fecal level will also be measured.
Who can join: Review the eligibility criteria below.
Location: University of California, San Diego — San Diego, California
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- University of California, San Diego — San Diego, California
- St.Jude Clinical Research — Doral, Florida
- AP Medical Research — Miami, Florida
- Edward Jenner Research — Plantation, Florida
- Altoona Center for Research — Duncansville, Pennsylvania
- Prolato Clinical Research Center — Houston, Texas
📞 Contact the Study Coordinator
Phone: (650) 417-8556
Email: jstephens@risetherapeutics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Arthritis, Rheumatoid
- Chronic Pain in Rheumatoid Arthritis — Denver, Colorado
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) — Glendale, Arizona
- INFINITY™ With ADAPTIS™ Technology Study — Gilbert, Arizona
- Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis — Boston, Massachusetts
- Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis — Ann Arbor, Michigan
Explore by condition: All Arthritis, Rheumatoid clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.